ABSTRACT: Acetylation is a post-translational modification that occurs on thousands of proteins located in many cellular organelles. This process mediates many protein functions and modulates diverse biological processes. In mammalian cells, where acetyl-CoA is the primary acetyl donor, acetylation in the mitochondria is thought to occur by chemical means due to the relatively high concentration of acetyl-CoA located in this organelle. In contrast, acetylation outside of the mitochondria is thought to be mediated predominantly by acetyltransferase enzymes. Here, we address the possibility that nonenzymatic chemical acetylation outside of the mitochondria may be more common than previously appreciated. We employed the Nucleic Acid Programmable Protein Array platform to perform an unbiased screen for human proteins that undergo chemical acetylation, which resulted in the identification of a multitude of proteins with diverse functions and cellular localization. Mass spectrometry analysis revealed that basic residues typically precede the acetylated lysine in the −7 to −3 position, and we show by mutagenesis that these basic residues contribute to chemical acetylation capacity. We propose that these basic residues lower the pK a of the substrate lysine for efficient chemical acetylation. Many of the identified proteins reside outside of the mitochondria and have been previously demonstrated to be acetylated in vivo. As such, our studies demonstrate that chemical acetylation occurs more broadly throughout the eukaryotic cell than previously appreciated and suggests that this post-translational protein modification may have more diverse roles in protein function and pathway regulation. P ost-translational modifications (PTMs) of proteins provide the cell an additional level of regulation. These PTMs include phosphorylation, ubiquitination, glycosylation, and acetylation, as well as a vast assortment of other less studied or less abundant modifications. Along with the varied nature of the modifications, the effects of the PTMs can influence nearly every aspect of protein function, including stability, localization, binding affinities, and enzymatic activity and biological processes such as transcription and metabolism.
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The acetylation of the ε-nitrogen of the lysine side chain has long been studied as primarily a histone modification. In general, the action of any lysine acetyltransferase enzyme is to mediate the transfer of an acetyl group from the acetyl-CoA cofactor onto the lysine residue, while deacetylase enzymes work in opposition to this function. The classical view for this modification was that that the neutralization of the positively charged lysine side chain on the histone tails by acetylation facilitates DNA unwinding from the nucleosome, allowing for transcription and other DNA-templated activities. Currently a much broader role for these modifications has been appreciated since the discovery of histone PTMs. It has been demonstrated that these modifications do not directly contact the DNA but rather specifically influence the binding and activity of other transcription factors including bromodomain-containing proteins that specifically recognize acetylated lysine residues.
1,2
The acetylation of nonhistone proteins as a whole is less well understood, with a few exceptions. For example, the acetylation of the extreme C-terminal domain of the tumor suppressor p53 by the acetyltransferase p300 has been well documented, with the effect of increased transcription of p53 target genes. 3 Additionally, the acetylation by Tip60 of p53 on a distinct lysine residue regulates the apoptotic functions of p53. 4 Besides transcription factor acetylation, the microtubule protein α-tubulin has been shown to be acetylated, at least in part by the αTAT acetyltransferase. 5 This PTM increases the longevity of the microtubules, as well as facilitates vesicle trafficking. 6, 7 More recently, proteome wide mass spectrometry studies have shown that acetylation is a pervasive modification, with thousands of acetylated proteins located in many cellular organelles harboring multiple acetylation sites. 8, 9 These proteins are involved in nearly every cellular process, from transcription and translation to cytoskeleton remodeling and protein transport. 9 The presence of appropriate acetylation modifications is crucial to maintaining cellular function, and as such, a number of diseases and disorders have been shown to be correlated with aberrant acetylation. In the case of Tip60, misregulation of its target proteins has been implicated in the progression of Alzheimer's disease, 10 while p300 and CBP can act as tumor suppressor genes, with their dysfunction linked to numerous cancers. 11 In addition to their role in disease, acetylation may have bearing on the aging process, as it has been reported that activation of some Sirtuin family deacetylases may extend lifespan in model organisms. 12 Given the large number of functionally important acetylation sites across various cellular proteins, it becomes imperative to understand the mode of protein acetylation. The mode of protein acetylation which is most studied is mediated by protein acetyltransferase enzymes, which use the acetylcoenzyme A cofactor to acetylate protein substrates. 9 In addition, some protein acetyltransferases have been reported to autoacetylate themselves such as the MYST family of HATs: hMOF and Esa1, 13 PCAF, 14 Rtt109, 15 and p300. 16 Another mechanism of protein acetylation involves a chemical event, which requires no enzyme. Nonenzymatic acetylation has been historically reported for both histones and hemoglobin, and this reaction occurs at modest acetyl-coenzyme A concentrations, and under biologically relevant buffer conditions. 17, 18 More recently, evidence has emerged for nonenzymatic acetylation on a number of bacterial proteins, 19−21 as well as on eukaryotic proteins in the mitochondria. 20, 22, 23 While these studies have detailed a large number of chemically acetylated proteins, bacteria contain millimolar concentrations of acetyl-phosphate which can be used as the acetate donor, 19, 21, 24 and a similar situation exists in the mitochondria of mammalian cells, with up to 2 mM acetyl-CoA. 20 In contrast, the cytoplasm of mammalian cells contains less than 30 μM acetyl-CoA as the sole acetate donor, 23 and the mechanism of acetylation in this compartment has not been extensively studied.
Recent advances in printed protein arrays have allowed for near-proteome-wide biochemical analyses in a controllable way. 25 While protein arrays have been used previously for the study of protein acetylation, these have focused either on bacterial proteins or on peptide libraries. 21, 26 Here, we employed the Nucleic Acid Programmable Protein Array (NAPPA) platform, 20, 22, 27 which circumvents challenges of expression and purification of thousands of proteins in yeast or insect cells and the potential denaturation incurred during purification, printing, and storage as required by the conventional production of human protein arrays. Protein integrity is assured by the use of both mammalian expression machinery and chaperone proteins to synthesize and properly fold proteins immediately before assays. Using NAPPA, 28 we have screened a large subset of the human proteome for their ability to undergo chemical acetylation, leading to the identification and characterization of a diverse group of chemically acetylated proteins, which contain a signature sequence preceding the chemically acetylated lysine residue. The implications of these findings are discussed.
■ RESULTS
Adaptation of NAPPA to Screen for Chemically Acetylated Proteins. For initial protocol development, a small set of positive and negative control genes was selected to print onto a test array. The positive control genes (p300, CBP, PCAF, hMOF, and GCN5) were acetyltransferase enzymes, which had been shown to exhibit at least some degree of autoacetylation activity in vitro, 2,12−14,16 while the negative control genes (p53 and histone H4) were proteins that were demonstrated substrates of acetyltransferase enzymes. 29, 30 These genes were cloned into a FLAG-tagged in vitro translation vector. The plasmids were printed onto the array slide, alongside an α-FLAG antibody to immobilize each translated protein onto the array. Protein expression was initiated by the addition of a Hela cell based in vitro translation mixture. The expression mixture was supplemented with T7 polymerase, to transcribe the recombinant proteins, which were under the control of a T7 promoter. After washing, the final result is multiple pure, immobilized proteins displayed on the array slide. The quality of the printed plasmid DNA templates was assessed using pico-green staining ( Figure S1A ), and the protein expression and display was gauged using a second α-FLAG antibody ( Figure S1B ).
To determine the acetylation capability of each protein on the array, the displayed proteins were incubated with 14 C labeled acetyl-coenzyme A (acetyl-CoA). Two methods were tested, by acetylating the protein during the translation reaction (single-step method) or after the translation reaction was stopped. In the single-step method, 14 C-acetyl-CoA was simply added to the transcription/translation reaction. After a one month exposure to film, the 14 C incorporation was quantified by integration of the spot intensity on the film. In contrast, in the multi-step method, all attempts were made to start the radiolabeled acetylation reaction with a minimum of preexisting acetylation sites. First, the arrays were translated in the presence of the nonspecific acetyltransferase enzyme inhibitor s-acetonyl-CoA, 31 to inhibit any acetyltransferase enzymes which may be present in the translation mixture. Following expression, the arrays were fully deacetylated using high concentrations of the yeast histone deacetylase Hst2. Following this pretreatment, the arrays were then incubated with 14 Cacetyl-CoA and processed as described above. For both methods, in addition to arrays processed with full transcription/translation reaction mixtures, arrays were also processed lacking the T7 polymerase in the expression mixture, which should result in no recombinant protein production.
We observed that both methods could differentiate between the positive and negative control proteins (Figure 1) . In both cases, hMOF and PCAF showed the highest acetylation signal, as these enzymes are shown to have high intracellular autoacetylation activity, 2,32 and in the single-step method, p300 was also detected with a high signal, in line with its known autoacetylation activity. 16 Both methods did display some background signal in the negative genes as well as on the slides lacking the T7 polymerase, which was attributed to residual bacterial proteins contaminating the plasmid DNA. However, this background was consistent for each DNA template, and the signal-to-noise was more than sufficient in both methods to allow for distinguishing the positive and negative controls. There was a small distinction between the two methods in that the single-step yielded higher signal from the positives, albeit with a slightly higher background from the negative genes ( Figure 1B and C) , whereas the multi-step procedure resulted in a lower background, with a lower signal from the positive controls ( Figure 1D and E). Based on these results, we concluded that the arrays displayed sufficient protein levels to detect autoacetylation and selected the single-step procedure to test the full set of genes, as the increase in signal outweighed the higher background.
Use of NAPPA to Screen for Chemically Acetylated Proteins. Following protocol validation, arrays were produced with approximately 6000 genes. The plasmid DNA for these genes was taken from the DNASU collection and encoded a Cterminal FLAG or GST tag in an in vitro expression vector. The genes were split into four sets, resulting in about 1500 genes printed per array slide. The plasmid DNA was coprinted with a corresponding α-GST or α-FLAG antibody for immobilization. The arrays were processed using the single-step method, with the radiolabeled 14 C-acetyl-CoA added directly to the protein expression reaction. For each of the four array sets, three slides were produced with the full expression mixture, and two were produced with a translation mixture lacking the T7 polymerase.
After processing and exposure, the films were scanned, and the intensity of each spot was integrated (Figure 2A) .
By visual inspection of the films, there were often large areas on the film with an overall lower signal near the center of the glass slide. This was attributed to the surface tension of the reaction mixture creating a higher volume around the edge of the slide. To correct for this bias, a local area normalization was carried out on each slide, generating z scores for each spot. Using this approach, approximately 300 genes had a z score above 2, and approximately 1600 genes had z scores over 1. However, there was no clear delineation to mark the cutoff between positive hits and the background, as the genes fell into a continuous distribution. (Figure 2B ). Therefore, a secondary confirmation step was performed, and the top ranked 300 genes bases on the z score were selected and rearrayed in triplicate to produce a new confirmation array. These candidates were printed onto the array alongside positive and negative controls, as well as BSA and several other nongene controls.
For the confirmation stage, the arrays were processed using both the single-step and multi-step procedures, to allow for a cross-validation of the techniques. A total of 14 slides were used, with four being treated with the full expression mixture, and three lacking the T7 polymerase for each method ( Figure  3 ). Following the routine described earlier, the arrays were processed, and the spot intensities quantified and normalized. Each spot was individually ranked according to the z score as before, with the replicates being maintained separately. Many of the genes had a high z score in at least two replicates; however this correlation began to drop off below a z score of ∼1. This allowed for a more rational cutoff for selecting hits to move on to further validation, and as such the final selection criteria was that at least two of the three spots had a z score greater than 1, with the third spot having a positive value. This narrowed the list of positive hits to 31 proteins from the single-step method and 27 proteins from the multi-step method, with 11 proteins being common in the two sets, for a total of 47 unique candidate genes. In addition, 11 proteins were included which, by visual inspection, had noticeable and reproducible signal changes in the full array screen but did not meet the initial selection criteria for confirmation array printing.
In Vitro Validation of Chemically Acetylated Proteins. The mechanism of the acetylation for the 58 candidate genes was investigated next, as the observed signal could have been due to protein acetyltransferase activity (autoacetylation), or direct chemical acetylation. To dissect this, the genes selected for validation were investigated for autoacetylation activity in vitro using recombinant purified protein. The genes' functions represented a wide variety of cellular processes. For example, RPS26 and RPS28 are ribosomal subunits, MRPL17 and MRPL40 are mitochondrial ribosomal proteins, UBE2B is an ubiquitinating enzyme, KRT8 is a keratin, IGL@ is an immunoglobulin, and COX5 is a subunit of the cytochrome c complex. While some of the candidate genes were well characterized and unlikely to represent novel acetyltransferase enzymes, all of the candidate genes were recloned, expressed in E. coli, and purified using a GST affinity column. Of the proteins tested, 49 were produced at levels sufficient for acetylation studies in vitro (Table 1 and Figure S2 ). Prior to any acetylation studies, the candidate proteins were treated with high concentrations of the recombinant S. cerevisiae Hst2 protein deacetylase to remove any promiscuous acetylation events that may have occurred during the protein overexpression in E. coli. The purified proteins were then assayed for their ability to incorporate the radiolabeled acetate from 14 C-acetyl-CoA. After incubation with concentrations of 14 Cacetyl-CoA from 1 μM to 20 μM (the upper limit of the acetylCoA concentration that is thought to be present in growing eukaryotic cells), 33 the proteins were washed and the radioactivity counted ( Figure 4A and Table S1 ). Remarkably, all proteins assayed had incorporation of the radioactive acetyl group. We noted that the level of protein acetylation was significant and showed a dose response in relation to increasing 14 C-acetyl-CoA concentrations ( Figure 4A , left). However, when compared to the control acetyltransferase enzyme hMOF, the level of 14 C-acetyl incorporation in the candidate genes was 1 to 2 orders of magnitude lower ( Figure 4A , right). In addition, the level of protein acetylation did not plateau at high acetyl-CoA concentrations, even with acetyl-CoA concentrations as high at 300 μM ( Figure 4B , left and Table S1 ). This is in contrast to a more defined plateau at high acetyl-CoA concentrations for the hMOF acetyltransferase ( Figure 4B , right and Table S1 ). Since a second-order, enzymatically driven reaction, at saturating substrate concentration, would be expected to show a plateau of activity, these data were consistent with the chemical acetylation of these protein substrates. To test this possibility, we treated hMOF and the candidate proteins with equimolar concentrations (20 μM) of 14 C-acetyl-CoA and s-acetonyl-CoA, a nonhydrolyzable acetylCoA analog in which an extra carbon is inserted between the terminal sulfur of the CoA and the acetyl group, which functions as a nonspecific inhibitor of acetyltransferase enzymes but should have no effect on nonenzymatic acetylation. 31 This analysis revealed that the acetylation of the candidate proteins was not significantly inhibited by s-acetonyl-CoA, while in four cases (LARP1, FATE1, SMA4, and STK25) the incorporation was actually substantially increased, for reasons that are unclear. This was in contrast to the acetyltransferase hMOF, which The z score of each spot in the array comparing the signal change between control untranslated slides and slides processed using full translation mixtures. For each array, three full translation slides and two untranslated slides were prepared, and the average values from these sets were used to generate z scores.
showed more significant inhibition at the concentration of sacetonyl-CoA used ( Figure 4C and Table S1 ). The observation that hMOF did not show more complete inhibition of acetylation upon treatment with s-acetonyl-CoA suggested that hMOF may itself undergo chemical acetylation, and this possibility was later confirmed as will be addressed below. Taken together, these data suggested that the candidate proteins were chemically, rather than enzymatically, acetylated. This was further supported by the observation that the candidate proteins all had similar levels of acetylation, along with the identities of some of the proteins. A number of the candidates identified in the screen are well-studied proteins and are extremely unlikely to be acetyltransferase enzymes, including Birc5 (survivin), KRT8 (keratin), IGL@ (immunoglobulin), and STK25 (kinase). One protein in particular, hemoglobin (HBE1), clearly has no acetyltransferase activity but has previously been reported to undergo nonenzymatic acetylation. 17 Identification of a Chemical Acetylation Signature Sequence. To confirm that the signal observed in the in vitro acetylation experiments was due to acetylation on lysine side chains, 18 of the candidate proteins were selected for further analysis based on high acetylation signal in the radiolabeling experiments, as well as the level of expression and quality of the final purified protein. These candidate proteins were chemically acetylated and subjected to trypsinization and mass spectrometry analysis. All analyzed proteins contained at least one detectable acetylated lysine residue, and moreover, the pattern of acetylation was not random, as we found that acetylation occurred at preferred sites within each protein.
The distinct patterns of nonenzymatic acetylation led us to look for a signature sequence for chemical acetylation. The apparent percent acetylation at each site was estimated from the LC-MS/MS data as described in the Methods using spectral counts. Each modified site was categorized as high acetylation (apparent acetylation ≥20%) or low acetylation (apparent acetylation <20%), and the sequence ranging from −7 to +7 of the lysine in question was submitted to WebLogo3 34 to generate consensus sequences. Comparing the consensus sequences generated from the high ( Figure 5A ) and low ( Figure 5B ) acetylation sites revealed a large charge difference in the seven residues preceding the lysine in question. In particular, acetylated lysines tended to have at least one basic residue (lysine or arginine) in the −7 to −4 position, although many peptides had multiple basic residues from the −7 to −3 position ( Figures 5C and D) . In contrast, lysines with low levels of acetylation more often had acidic residues (glutamate or aspartate) and nonpolar residues (typically leucine) flanking the lysine, although the positional requirement seemed to be less stringent. To better quantify this, the pI values for the seven residues preceding the lysine were calculated for each sequence, and the values averaged. Peptides preceding highly acetylated lysines had an average pI value of 9.1 with a SEM of 0.37, while low acetylation peptides had an average pI value of 5.3 with a SEM of 0.39.
To test the requirement of the preceding basic residues for lysine chemical acetylation, we mutated these residues to alanine in three test proteins, BIRC5, DTYMK, and DOK4 ( Figure 6A) , and compared the level of lysine acetylation in the wild-type and mutated sequences. Specifically, the proteins were first fully deacetylated and then reacted with acetyl-CoA. Replicate aliquots of DTYMK were digested with trypsin or GluC. Replicate aliquots of DOK4 were digested with trypsin or AspN, and an aliquot of BIRC5 was digested with trypsin. To directly compare the acetylation yields of the wild-type and mutant proteins, the integrated peak areas of the corresponding acetylated peptides in the two samples were compared. In the case of Glu-C and AspN, this meant the comparison was between the identical peptide from the two samples, while the tryptic peptides between mutant and wild-type protein were similar but not identical as the mutation removed a trypsin cleavage site. However, the calculated decreases in acetylation of the target site in the mutant proteins were similar for both the tryptic and nontryptic peptides; therefore, the results from the two proteases were averaged. In a striking fashion, in all cases, the mutated proteins had large decreases in acetylation at the lysine following the mutation site ( Figure 6B ), while the levels of acetylation in the remainder of the proteins remained unchanged ( Figure S3 ). These data strongly suggest that chemical lysine acetylation depends on the presence of preceding basic residues.
Correlation with Whole Cell Acetylomics Studies. Although we have demonstrated that nonenzymatic protein lysine acetylation can occur at physiological acetyl-CoA concentrations in vitro, we were curious about whether this phenomenon carries over to an in vivo environment. To assess this, our final list of 58 validated chemically acetylated proteins in vitro was compared to published whole cell proteomics data (Table 1) , to determine if the chemically acetylated sites that we identified had been previously observed in vivo. In total, 28 of 49 (57%) of the proteins that we validated to be chemically acetylated in vitro were also observed to be acetylated in whole cell proteomics studies (Table 1 ). In addition, several proteins that we analyzed for site-specific acetylation using mass spectrometry identified the same specific modified residues as found in the proteomics studies. For example, the protein survivin, well studied for its role in the cell cycle and as a substrate of CBP, was shown to have a number of lysine residues acetylated in vivo. We demonstrated that three of these lysine residues in particular, Lys23, Lys115, and Lys122, 35 were all chemically acetylated in our study. After overnight treatment with acetyl-CoA, residues Lys23 and Lys122 were found to be more than 50% chemically acetylated, while Lys115 was fully acetylated. The protein fascin (FSCN1), involved in actin organization, when treated similarly had apparent complete acetylation on Lys471, which was previously observed to be aceylated in whole cell proteomics studies. 9 The ribosomal subunit RPS26 had two lysine residues with correlation between our study and whole cell proteomic studies, Lys66 9 and Lys82, 36 although Lys66 was only acetylated to low levels in our hands. Lys169 of the dTMP kinase has been reported to be acetylated in vivo and was found to be ∼10% acetylated by chemical means in our study. Given these extensive correlations between the chemical acetylation sites that we identified in vitro and prior demonstration that the same sites were acetylated in cells, we propose that many, if not all, of the sites that we have identified to be chemically acetylated in our confirmation studies in vitro may, in fact, become acetylated by chemical means in cells.
hMOF Lysine 274 Autoacetylation. Upon examination of the sequences of the MYST family of acetyltransferases, a perfectly conserved, positively charged lysine residue (Lys268 in hMOF) was observed in the −6 position relative to the reported autoacetylated lysine residue (Lys274 in hMOF), within a region of generally low sequence similarity ( Figure  7A ). In the enzyme hMOF, Lys274 is located in a loop region, and acetylation of this residue appears to trigger a structural rearrangement of the Lys274 bearing loop from outside to inside the enzyme active site, a rearrangement that appears to be critical for hMOF acetylation of cognate substrates. 13, 19, 24 As the sequence surrounding this lysine appeared to share the signature sequence of a preceding basic residue, a short peptide spanning residues 261−278 of hMOF was synthesized to test the nonenzymatic acetylation of this lysine residue. Additionally, peptides containing an arginine or methionine at the −6 position, rather than the endogenous lysine, were generated, to assess the role of the preceding basic residue. Upon incubation with increasing amounts of radiolabeled acetyl-CoA, only peptides with a positively charged residue in the preceding position were efficiently acetylated, and the level of acetylation was linear with respect to acetyl-CoA concentration (Figure 7B). To confirm the acetylation status of the peptides, peptides were treated with 200 μM acetyl-CoA and subjected to MALDI mass spectrometry. Consistent with the radioassay, only the lysine and arginine containing peptides showed detectable acetylation, as seen as a peak with a mass shift of 42 Da ( Figure  7C ). While these peptide assays cannot determine the actual mechanism of Lys274 acetylation in the intact enzyme, these data suggest that this modification is at least capable of happening in an nonenzymatic fashion, dependent on the preceding basic residues. This may reflect the full mechanism of the modification in vivo, or it may function as a redundancy to ensure that this residue is always acetylated in the cell.
■ DISCUSSION
We have successfully employed the NAPPA array to identify human proteins that undergo nonenzymatic (chemical) acetylation. Further site-specific analysis of a subset of these proteins revealed that these chemically acetylated lysine residues typically have a pattern in the preceding sequence, where basic residues are found in the −7 to −3 positions. The basis of the increased chemical reactivity of these lysine residues remains unknown; however, it is likely the preceding basic residues function to sufficiently lower the pK a of the substrate lysine so that an enzyme is not required to deprotonate the side chain, thus allowing the acetylation reaction to occur spontaneously. The possibility of positive residues spatially near a lysine residue affecting the pK a of its terminal amines has been recently discussed. 20 The distance between the preceding basic residue and the acetylated lysine in the signature sequence may act to provide enough flexibility for the preceding residue(s) to come into proximity and effect the reactivity of the target lysine. An additional possibility is that the positive residues may provide a docking site for the negatively charged phosphates of the acetyl-CoA, in analogy to the mechanism proposed for acetylation in bacteria by acetyl-phosphate. 21 However, in the case of acetyl-phosphate acetylation, a negatively charged residue in the −1 position was required, which we do not observe in the peptides acetylated by acetylCoA.
Previous studies of chemically acetylated proteins in bacterial and mitochondrial proteins have demonstrated a correlation between chemically acetylated sites and 3-D protein environment. 20 In contrast, our comparison of available 3-D structures containing "low" and "high" chemically acetylated sites ( Figure  5A and B) reveals no statistically significant difference between the two types of sites for (1) the number of nearby positive residues, (2) the solvent accessibility, or (3) the secondary structure (Table S2 ). Based on these observations, we conclude that, at least in the case of the mammalian proteins that we analyzed, the propensity of a particular lysine residue to undergo chemical acetylation does not correlate with its 3D environment, but that the sequence features noted in Figure 5A and B appear to be the most indicative factor in the propensity for a certain lysine residue to undergo chemical acetylation.
Several of the acetylated lysine residues identified in our analysis also overlap with lysine residues which have been shown to be acetylated in whole cell proteomics studies, implying that these residues may be chemically acetylated sites in vivo. However, as the whole cell proteomics studies performed in mammalian systems specifically selected for acetyllysine containing peptides, determining a stoichiometry of acetylation in the cell would not be possible; so it remains unclear if these sites are acetylated to a high degree in the cell or rather exist at background levels. Additionally, it is not surprising that some chemically acetylated proteins identified in this study would have been missed in prior acetylome studies because identification of post-translational modifications in low abundance proteins, especially when such modifications are likely substoichiometric, are very challenging and incomplete in global analyses. Further investigation of the remaining chemical acetylation sites that we identified will be necessary to determine whether these remaining modifications also occur in vivo.
Interestingly, while chemical acetylation has previously been proposed to occur in the mitochondria, 20, 22 we noted that most of our identified targets reside in the cytosol, nucleus, and other organelles. The mitochondrial compartment contains millimolar concentrations of acetyl-CoA, approximately 100× more than is found in the cytoplasm. 23 These relative concentrations may, in fact, explain our candidates being skewed away from the mitochondria. On an absolute scale, a protein would need to be much more easily acetylated, if that protein were in an environment with lower acetate donor concentrations. And as we exposed all of the candidate proteins to the same concentrations of acetyl-CoA, regardless of their cellular localizations, we would select for proteins most easily acetylated, which would tend toward nonmitochondrial proteins. Overall, this has resulted in the first large-scale identification of mammalian proteins capable of chemical acetylation, which are not localized to the mitochondria.
In retrospect, while many nonhistone acetylation sites have been determined, primarily by global proteome analysis after enrichment of acetylated peptides, few have been shown to be the direct result of an enzymatic modification. 9, 20, 22 Inspection of the known nonhistone enzymatic sites shows a mixture of sequences with and without preceding basic residues ( Figure  8 ), but in general, there are fewer preceding basic residues in the enzymatic sites overall compared with the chemical acetylation consensus sequence identified here. Specifically, in the case of the enzymes αTAT1 and hMOF, the sequences before the substrate lysine have no positive residues, 5, 26, 37 while in the case of Esco1, PAT, and PCAF, some sites contain at least one basic residue in the −7 to −3 position, 38−40 in line with the previously determined signature sequence. Of note, a peptide containing the Lys105 site of the substrate SMC3 can be very efficiently chemically acetylated in vitro (unpublished data). This may indicate that the site is acetylated by multiple means in the cell or that the lysine can be simply more efficiently acetylated by the enzyme in the cell. This reasoning may extend to the other enzymatic sites which show preceding basic residues, in that the positive residues can serve to lower the pK a of the substrate lysine, allowing more efficient acetylation, either chemically or enzymatically.
A remaining question is the biological role of the nonenzymatic acetylation sites. Whereas acetylation by enzymes has been shown to affect protein binding affinities, stabilities, and cellular localizations, 35, 41, 42 and is well-known to act as a reversible switch, 29, 41, 43, 44 the impact of nonenzymatic acetylation is unknown. Also, it is not clear if the nonenzymatic acetylation sites exist in equilibrium or are biologically intended to always be acetylated. It is also possible that the acetylation of Figure 6 . Mutational analysis of basic residues preceding the lysine target of chemical acetylation highlighting the importance of these residues for chemical acetylation. (A) Sequence of peptides surrounding highly acetylated lysines (indicated by arrow) and the preceding basic residues mutated to alanine (indicated by underline). (B) Normalized levels of acetylation of the indicated lysine in the wild-type protein and the mutant as determined by digestion and LC-MS/MS. For DTMYK, the protein was individually digested with trypsin and GluC, and the indicated level is the average normalized area of the acetylated peptides from the two protease reactions. DOK4 was digested with trypsin and AspN and similarly analyzed. In the case of BIRC5, only trypsin gave coverage of the peptide in question, so no averaging was possible (indicated by a *).
these sites could act as a sensor to respond to the concentration of acetyl-CoA in the cell. As high acetyl-CoA concentrations are a cellular signal for an upregulation of cellular metabolism, 33 this would linearly increase the first-order reaction of nonenzymatic acetylation, resulting in modulation of protein functions.
These studies have important implications for the activity of the MYST family of protein acetyltransferases. It has been established that these enzymes must be autoacetylated on Lys262 of yeast ESA1 and Lys274 of human MOF to be functional. 12 This was originally attributed to a cis-enzymatic acetylation, as the acetylated lysine is near the active site of the enzyme and exhibits first order reaction kinetics in regards to protein concentration. 13 However, we have demonstrated that in the context of short peptides, the region surrounding the lysine is sufficient for nonenzymatic acetylation, and moreover, the presence of the preceding basic residue is necessary for this modification to occur. While the mechanism in the intact enzyme cannot be fully described by these experiments, the contribution of chemical acetylation to Lys274 modification is supported by the fact that a catalytically inactive mutant of hMOF is able to undergo Lys274 acetylation, 13 and that sacetonyl-CoA cannot completely inhibit the autoacetylation of this lysine in hMOF ( Figure 4C) .
The unrelated acetyltransferase enzyme p300 has also been shown to have a lysine rich activation loop, which requires acetylation to generate the active enzyme. 16 Investigation of the loop sequence reveals that the acetylated lysines responsible for enzymatic activity show a nonenzymatic acetylation consensus sequence, with each acetylated residue being preceded by positive residues in the −5 to −3 positions (Figure 9 ). While studies to date have demonstrated that p300 is able to acetylate these lysine residues, 16 it is possible that some of this acetylation occurs through chemical means.
Taken together, these studies add chemical acetylation to the toolbox of how many proteins in different cellular organelles can be modified. While the major biological roles of nonenzymatic acetylation and its regulation are unknown, it is likely that the process is much more common than previously appreciated, and must be considered when investigating the mode of protein acetylation.
■ METHODS
Cloning. To generate positive and negative controls for initial establishment of assay protocols on NAPPA, each gene was cloned into the pANT7-cGST in vitro expression vector encoding a Cterminal GST tag using the Gateway recombination cloning system. 21 To generate vectors for E. coli expression, genes were PCR amplified from the templates in pANT7-cGST (https://DNASU.org) and cloned into the pET-BAPP vector. The pET-BAPP vector was generated from the pET-DUET backbone, which was then edited to generate a single expression cassette containing an N-terminal GST tag, followed by a TEV cleavage site. The multicloning site of the vector was re-engineered to contain the BamHI site followed by the 8-cutter restriction sites for AsisI, PacI, and PmeI. All PCR amplified genes were digested with AsisI and PmeI, followed by ligation into a similarly cut vector. All vectors were sequenced to confirm the presence and fidelity of the insert.
Array Printing. Array production and quality control were performed as previously described. 28 Template DNAs were obtained from the DNASU collection (https://DNASU.org), a set of plasmid DNAs which have a focus on human ORFs in FLAG or GST tagged in vitro translation vectors. Plasmid DNA was prepared in a 96 well format and resuspended in water. BSA, anti-tag antibody (anti-GST from GE Healthcare or anti-FLAG from Sigma), and BS3 linker (Pierce) were added to a final concentration of 3.7 mg mL −1 , 375 μg/ μL, and 5 mM, respectively. Printing mixtures were incubated overnight at 4°C before being arrayed onto aminosilane (Pierce) coated glass slides by GenetixQArray2 using 350 μm solid pins. Printed plasmid DNA was visualized by picogreen staining (Life Technology) to assess printing quality. We used anti-tag antibodies different from the capture antibodies printed on the arrays (anti-GST from Cell Signaling and anti-FLAG from Sigma) to assess protein display on arrays after cell free expression using 1-Step Human Coupled in vitro Expression Kits (Thermo).
Array Processing. NAPPA arrays were expressed using one of two general methods. In both cases, printed arrays were blocked for 1 h in SuperBlock Blocking Buffer (ThermoScientific) followed by five rinses with dH 2 O. The slides were further blocked with incubation with 500 μM cold acetyl-CoA for 2 h in 20 mM Tris-HCl at pH 7.8 and 50 mM NaCl. Following blocking, the slides were dried under compressed air and a Hybriwell gasket (Grace Bio-Laboratories) applied. The slides were then translated using the 1-Step Human Coupled IVT Kit (Pierce) according to the manufacturer's instruction for 90 min at 30°C followed by 45 min at 15°C. For the single-step method, the translation mixture was supplemented with 300 μM 14 C-acetyl-CoA, and following translation the slides were immediately washed with TBST buffer. For the multi-step method, the translation mixture was supplemented with 400 μM s-acetonyl-CoA. The slides were then washed extensively with 20 mM Tris-HCl at pH 7.8 and 100 mM NaCl, followed by an overnight, room-temperature incubation with 300 μM 14 C-acetyl-CoA in the same buffer. The slides were then washed extensively with TBST. For both methods, the slides were rinsed with dH 2 O and then dried completely under compressed air. The dry slides were then applied to high resolution, single emulsion film and incubated at −80°C for approximately 30 days, after which the film was developed and scanned.
Array Analysis. After processing, spot intensity from scanned film images were quantified using ArrayProImage Analyzer for downstream data analysis. The normalized intensity of each spot on the array was calculated by dividing the intensity of the spot by the average intensity of the spots in an 11 × 11 box surrounding it. The normalized intensities from replicate slides were then averaged, and the average intensity of the (−) T7 Polymerase slides was subtracted from the full reaction slides. The change in each spot's intensity was ranked by standard deviations in the local area (local area z score). The final values for the total collection of genes ranged between −3.5 and 3.5σ, with the negative z scores generated by the surrounding genes having increased signal, resulting in a lower normalized value.
Protein Expression. Expression plasmids encoding the genes of interest were transformed into BL21 (DE3) cells and grown in 1 L of TB media to an OD 600 of 0.8. Protein expression was induced with 0.5 mM IPTG for 12−16 h at 20°C. Following expression, the cells were pelleted and resuspended in PBS supplemented with 300 mM NaCl, 2 mM β-ME, and 0.1 mg mL −1 PMSF. Cells were lysed by sonication and then centrifuged to remove insoluble material. The cleared lysate was then incubated with 0.5 mL of GST resin (Gold Bio) for 2 h at 4°C
. The beads were washed three times with 50 mL of PBS plus 300 mM NaCl and 2 mM β-ME and then applied to a gravity flow column. The resin was further washed with PBS plus 300 mM NaCl and 2 mM β-ME, after which the proteins were deacetylated for ∼12 h at RT with 0.5 mg mL −1 HST2 dissolved in PBS plus 1 mM NAD + . The resin was washed extensively with the supplemented PBS buffer described above, followed by washing with unsupplemented PBS buffer. The resin was resuspended with 0.5 mL of PBS for assaying. Protein concentration was estimated by denaturing 100 μL of resin slurry with 500 μL of 6 M guanidine-HCl and determining the absorbance at 260 nm. Concentration measurements were confirmed by densitometry of coomassie stained SDS-PAGE gels.
In Vitro Assay. To assay for acetylation, 25 μL of resin slurry was incubated with varying concentration of 14 C-acetyl-CoA dissolved in 20 mM Tris at pH 8.0 and 200 mM NaCl. The reaction was allowed to proceed for 3.5 h at RT and was then applied to a glass-fiber filter plate (Millipore). After pulling through the reaction mixture, the retained resin was washed three times with 200 mM Tris at pH 8.0 and 200 mM NaCl, after which 100 μL of scintillation fluid was added and the plate sealed. Incorporation was measured by counting on a 96-well Figure 9 . Putative autoacetylation sites of p300/CBP HATs revealing chemical acetylation signature sequences. Sequence alignment of human p300, human CBP, and mouse CBP. Lysine acetylation necessary for catalytic activity indicated by red arrows. For each necessary acetylation site, at least one basic residue is present between the −5 and −3 positions.
TopCount scintillation counter, and all counts were normalized by the mass of protein present in the sample.
Mass Spectrometry and Peptide Analysis. The purified proteins immobilized on resin were acetylated using 300 μM acetylCoA in 20 mM Tris at pH 8.0 and 200 mM NaCl for 3 h at RT. SDS sample loading buffer was added to stop the reaction, and ∼10 μg of each sample was applied to an SDS-PAGE gel, which was then stained with coomassie R-250. Bands corresponding to the appropriate molecular weight of each sample were excised and digested with trypsin. In some cases, replicate samples were also digested with either GluC or AspN.
Peptides were loaded into a UPLC Symmetry trap column (180 μm inner diameter × 2 cm packed with 5 μm C18 resin, Waters), and separations were performed on a 15 cm PicoFrit column (75 μm inner diameter, New Objective) packed with Magic 5 μm C18 reversedphase resin (Michrom Bioresources) using a nanoflow high-pressure LC system (Eksigent Technologies), which was coupled online to a LTQ-Orbitrap XL mass spectrometer (Thermo Fisher Scientific) via a nanoelectrospray ion source. Chromatography was performed with Solvent A (Milli-Q water with 0.1% formic acid) and Solvent B (acetonitrile with 0.1% formic acid). Peptides were eluted at 200 nL/ min for 5−30% B over 75 min, 30−80% B over 5 min, and 80% B for 10 min before returning to 5% B over 1 min. To minimize sample carryover, a fast blank gradient was run between each sample. The LTQ-Orbitrap XL was operated in the data-dependent mode to automatically switch between full scan MS (m/z 300−2000) in the Orbitrap analyzer (resolution of 60 000 at m/z 400) and fragmentation of the six most intense ions exceeding a minimum threshold of 1000 by collision-induced dissociation in the ion trap mass analyzer. Monoisotopic precursor selection was enabled, and charge state screening was enabled to reject ions with undefined charge state. Ions subjected to MS/MS were excluded from repeated analysis for 20 s.
MS/MS spectra were extracted and searched using the SEQUEST algorithm in BioWorks (version 3.3.1, Thermo Fisher Scientific) against a combined E. coli proteome database and the recombinant protein sequences. The reversed sequences of the database and a list of common contaminants were also appended. MS/MS spectra were searched using partial specificity for the expected target sites of the protease that was used with up to two missed cleavages, a 100 ppm precursor mass tolerance, 1 amu fragment ion mass tolerance, static modification of cys by carbamidomethylation (+57.0215), and variable modifications for methionine oxidation (+15.9949), asparagine deamidation (+0.9840), and lysine acetylation (42.0106). Consensus protein lists were generated by DTASelect (version 2.0, Scripps Research Institute, La Jolla, CA) using the following data filter: 10 ppm precursor mass accuracy, ΔCn ≥ 0.05, and requiring a minimum of three peptides per protein. The peptide false discovery rate was less than 1%.
Estimation of Acetylation Levels at Specific Lysines. In order to develop a chemical acetylation consensus sequence signature, sites of acetylation were detected by LC-MS/MS analysis of tryptic digests of target proteins excised from SDS gels. The extent of acetylation at each modified lysine was estimated by dividing the number of times a given lysine was identified in a sequence in its acetylated form (acetylated spectral counts) by the total spectral counts for all sequences containing that lysine in either its modified or unmodified state. This is a rough estimate because trypsin does not cleave at acetylated lysines, and the MS ionization efficiencies for complete tryptic cleavages of unmodified lysines, incomplete cleavages with internal unmodified lysines, and incomplete cleavages containing a modified lysine will usually be different. As a result, the number of spectral counts of these different forms of a given sequence will not directly correspond to molar yields. However, analysis of tryptic peptides produced more extensive sequence coverage and detection of acetylation sites than other proteases, thereby limiting the value of alternative approaches. In addition, this method will typically underestimate acetylation levels because in general, complete cleavages at unmodified peptides will yield stronger signals and spectral counts per femtomole than incomplete peptides either with or without modification of the internal lysine. Hence, this is the most practical method to globally estimate the "apparent percent modification" for a relatively large number of proteins of interest. After ranking the peptides by apparent percent acetylation, the signature sequence was determined by supplying the peptides with 20−100% acetylation versus 1%−20% acetylation to the WebLogo3 web server. 34 pI prediction calculations were performed on the peptides using an adaptation of the half-interval search algorithm, which excluded the contribution of N-and C-termini.
Comparison of the acetylation level of specific lysine residues in several wild-type and mutant proteins was performed by integrating the acetylated peptide peak area of the extracted ion chromatogram for the mutant protein and comparing it to the peak area of the corresponding peptide from the wild-type protein. To correct for differences in sample load, data were corrected based on the peak areas of two to four nonacetylated peptides for each digest of the mutant and wild-type protein. For comparison, the corrected peak area of the acetylated peptide from the wild-type protein was set to 1.0.
hMOF Peptide Acetylation Assay. Peptides corresponding to residues 261−278 of hMOF were synthesized. The peptides were tested for acetylation by incubation with acetyl-CoA in NaCl and 20 mM Tris at pH 8.0 for 3 h. For radioactive experiments, 14 C labeled acetyl-CoA was used between 1 and 200 μM, after which the pH was lowered using sodium acetate at pH 5.5, after which it was spotted onto P81 filter paper. The paper was washed three times with 20 mM sodium acetate at pH 5.5, and incorporation was measured by counting in scintillation fluid. For MALDI analysis, the reaction was performed using 200 μM cold acetyl-CoA. The reaction was mixed 1:1 with 10 mg mL −1 α-cyanno-4-cinnamic acid (Sigma), spotted onto a 96 well coated plate, and analyzed on an ABI/PerSeptive Voyager DE-PRO MALDI-TOF instrument in positive ion mode. 
